Neurologic and Neuroscientific Evidence in Aged COVID-19 Patients
The COVID-19 pandemic continues to prevail as a catastrophic wave infecting over 111 million people globally, claiming 2. 4 million lives to date. Aged individuals are particularly vulnerable to this disease due to their fraility, immune dysfunction, and higher rates of medical comorbidities, among...
Main Authors: | Shraddha Mainali, Marin E. Darsie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2021.648662/full |
Similar Items
-
Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review
by: Graziella Orrù, et al.
Published: (2020-09-01) -
Neurologic manifestations of COVID-19: what can we learn from other coronaviruses
by: Zohreh Jadali
Published: (2020-11-01) -
Neurological problems in the context of COVID-19 infection in Egypt. A multicenter retrospective analysis
by: Mohammed A. Azab, et al.
Published: (2021-12-01) -
Acute and Post-Acute Neurological Complications of COVID-19
by: Ali Al-Ramadan, et al.
Published: (2021-03-01) -
Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis
by: Vishakha Singh, et al.
Published: (2021-01-01)